Vanguard Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$393K Buy
40,466
+11,695
+41% +$135K ﹤0.01% 2270
2026
Q2
$335K Hold
28,771
– – ﹤0.01% 2312
2026
Q1
$483K Buy
+28,771
New +$515K ﹤0.01% 2109

Other funds holding CLB

Vanguard Asset Management's CLB Position: Q3 2026 in Review

Vanguard Asset Management increased its Core Laboratories (CLB) stake by 41% in Q3 2026, buying an estimated $135K and bringing the position to 40,466 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #2270.

Vanguard Asset Management first reported a position in CLB in Q1 2026 and has held it in 3 quarters since. The position peaked at $483K in Q1 2026. 180 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • Vanguard Asset Management held 40,466 shares of Core Laboratories worth $393K as of Q3 2026.
  • Vanguard Asset Management bought 11,695 Core Laboratories shares in Q3 2026, an estimated $135K.
  • Core Laboratories made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2270 holding.
  • Vanguard Asset Management first reported a position in Core Laboratories in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Asset Management's Core Laboratories position peaked at $483K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.